Mercury Laboratories Ltd.
BSE: 538964 | Sector: Health care |
NSE: N.A. | ISIN Code: INE947G01011 |
BSE 00:00 | 01 Feb | 765.15 |
-33.35 (-4.18%) |
OPEN
760.10 |
HIGH
795.00 |
LOW
760.10 |
NSE 05:30 | 01 Jan | Mercury Laboratories Ltd |
OPEN | 760.10 |
PREVIOUS CLOSE | 798.50 |
VOLUME | 65 |
52-Week high | 1000.00 |
52-Week low | 390.00 |
P/E | 15.33 |
Mkt Cap.(Rs cr) | 92 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Mercury Laboratories Ltd. (MERCURYLABS) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Sun Pharma.Inds. | 1014.15 | -20.85 | -2.01 | 15585.98 |
Dr Reddy's Labs | 4350.50 | 26.50 | 0.61 | 14405.20 |
Cipla | 1032.30 | 15.30 | 1.50 | 13091.79 |
Lupin | 736.30 | -1.65 | -0.22 | 11771.67 |
Aurobindo Pharma | 412.55 | 4.25 | 1.04 | 11287.14 |
Divi's Lab. | 3355.85 | 38.40 | 1.16 | 8879.82 |
Alkem Lab | 3033.10 | 23.35 | 0.78 | 8829.81 |
Glenmark Pharma. | 382.65 | -1.60 | -0.42 | 8141.58 |
Zydus Lifesci. | 435.60 | 4.85 | 1.13 | 7981.90 |
Torrent Pharma. | 1533.70 | 12.25 | 0.81 | 6742.32 |
Apollo Hospitals | 4268.10 | 12.55 | 0.29 | 6098.30 |
Ipca Labs. | 853.55 | 3.40 | 0.40 | 5399.36 |
Alembic Pharma | 540.00 | 1.90 | 0.35 | 5035.41 |
Abbott India | 20698.40 | -144.00 | -0.69 | 4919.27 |
Laurus Labs | 334.55 | 4.15 | 1.26 | 4707.04 |
Gland Pharma | 1263.05 | -37.15 | -2.86 | 4400.71 |
Granules India | 291.30 | -4.60 | -1.55 | 3238.44 |
Glaxosmi. Pharma | 1250.75 | 4.05 | 0.32 | 3217.51 |
Ajanta Pharma | 1184.10 | -24.30 | -2.01 | 3140.64 |
Piramal Pharma | 100.50 | -4.40 | -4.19 | 3094.95 |
Quick Links for Mercury Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices